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Abstract. Cells are capable of adhering to and mi-
grating on protein components of the extracellular ma-
trix. These cell-matrix interactions are thought to be
mediated largely through a family of cell surface re-
ceptors termed integrins. However, the manner in
which individual integrins are involved in cell adhe-
sion and motility has not been fully determined. To
explore this issue, we previously selected a series of
CHO variants that are deficient in expression of the in-
tegrin a5ß1, the "classical" fibronectin receptor. Two
sets of subclones of these variants were defined which
respectively express -20% or 2% of fibronectin re-
ceptor on the cell surface when compared to wild-type
cells (Schreiner, C. L., J. S. Bauer, Y N. Danilov, S.
Hussein, M . M. Sczekan, and R . L. Juliano. 1989. J.
Cell Biol. 109:3157-3167) . In the current study, the
variant clones were tested for haptotactic motility on
substrata coated with fibronectin or vitronectin . Data
from assays using fibronectin show that cellular motil-
ity of the 20% variants was substantially decreased
NTEGRINs are transmembrane glycoprotein receptors
which participate in a wide variety of cellular functions
including cell-cell interactions, and the adhesion of
cells to extracellular matrix (ECM) proteins such as fibro-
nectin (Fn), I laminin, collagen, and vitronectin (Vn) (Aki-
yama et al., 1990; Hemler, 1990; Hynes, 1987; Juliano,
1987; Ruoslahti and Pierschbacher, 1987). Integrins exist on
the cell surface as heterodimers of noncovalently associated
a and ß subunits. Some integrins interact with their respec-
tive ligands through RGD sequences contained within cer-
tain ECM proteins, while other integrins recognize non-
RGD sites in proteins (Gehlsen et al ., 1988; Hall et al .,
1990; Sonnenberg et al ., 1990). Several integrins which
share the ßl subunit are known to be receptors for Fn; this
would include a5ß1, the "classical" Fn receptor (FnR), as
well as 00 1, a4ß1, and the recently described receptoravß 1
(Brown and Juliano, 1985, 1987; Carter et al., 1990; Dedhar
and Gray, 1990; Elices et al., 1991; Guan and Hynes, 1990;
1. Abbreviations used in this paper: ECM, extracellular matrix; Fn, FnR,
fibronectin, fibronectin receptor; HpmF, high powered microscope field;
Vn, VnR, vitronectin, vitronectin receptor.
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(30-75 % of wild type), while the motility of the 2
variants was nearly abolished (2-20% of wild type) .
Surprisingly, a similar pattern was seen for haptotactic
motility of both 2% and 20% variants when vitronec-
tin was used (=20- 30% of wild type) . The reduced
haptotactic motility of the fibronectin receptor-
deficient variant clones on vitronectin was shown not
to be due to reduced vitronectin receptor (avß3) ex-
pression nor to a failure of these variants to adhere to
vitronectin substrata. Transfection of the deficient vari-
ants with a cDNA for the human a5 subunit resulted
in normal levels of fibronectin receptor expression (as
a human a5/hamster ß1 chimera) and restored the
motility of the CHO variants on fibronectin and
vitronectin. This indicates that expression of the a5
subunit is required for normal haptotactic motility on
vitronectin substrata and suggests that the fibronectin
receptor (a5#1) plays a cooperative role with vitronec-
tin receptors in cell motility.
Hemler, 1990; Pytela et al., 1985 ; Straus etal., 1989; Täkada
et al ., 1988; Vogelet al., 1990). Several integrins are known
to bind Vn, including the classical Vn receptor (avß3)
(Suzuki et al., 1986) and the platelet integrin glycoprotein
1Tb/IIIa (Charo et al., 1986; Phillips et al., 1988; Ponz et al.,
1987). Associations of the av subunit with other novel ß
chains to form putative Vn receptors have been described re-
cently, but the properties of these receptors are not well de-
fined (Cheresh et al., 1989; Ramaswamy and Hemler, 1990;
Sheppard et al., 1990; Suzuki etal., 1990). The ligand bind-
ing patterns of some integrins can be quite promiscuous; for
example, the platelet integrin Ilb/IIIa binds to fibrinogen,
Fn, von Willebrand factor, and Vn, while the avß3 VhR re-
portedly binds von Willebrand factor, thrombospondin,
fibrinogen, and Fn (Hemler, 1990; Phillips et al., 1988;
Charo et al., 1990; Pytela et al., 1986). By contrast, the
a5ß1 integrin has not been reported to bind any ligand other
than Fn.
Although integrin receptors have been implicated in sev-
eral aspects ofcell behavior including adhesion and motility,
the extent to which individual members of the integrin fam-
477ily are involved is less clear. This study was designed to in-
vestigate the role ofthe classical FnR (a5ßl) in the adhesion
and motility of cells on ECM proteins. Most previous studies
of the function of the FnR have relied on the use of RGD-
containing peptides or protein fragments, or on antibodies
that bind Fn or a5ß1, to perturb the interaction of the FnR
with its ligand (Brown and Juliano, 1985; Gehlsen et al.,
1988; Hayman et al., 1985a). As an alternative approach,
we have selected and cloned a series of stable FnR-deficient
variants from the CHO cell line (Schreiner et al., 1989).
Using ELISAand flow cytometric techniques with anti-FnR
monoclonal antibodies, two sets of clones were selected
which, on average, express either 20% (from here on 20
FnR variants) or 2 % (from here on 2 % FnR variants) of
wild-type FnR levels.
It is clear from many studies that cell adhesion and motil-
ity on a substratumcoated with a particular ECM protein in-
volves the integrin(s) which recognizes that protein. We be-
lieve, however, that this scenario is incomplete. This report
provides evidence that the a5ß1, which specifically binds
Fn, is involved in the haptotactic motility of cells on sub-
strata other than Fn. Thus, the presence of the 001 FnR is
required for motility even when other integrins mediate the
adhesion of cells to the substratum.
Methods andMaterials
Cell Culture
CHO cells were grown and maintained as previously described (Danilov
and Juliano, 1989; Schreiner et al., 1989). Cells were either grown as
monolayers in alpha-MEM (Gibco Laboratories, Grand Island, NY) sup-
plemented with 10% FBS (Hazelton Research Products, Inc., Denver, PA)
and 1% antibiotic-antimycotic mixture (Gibco Laboratories) or in suspen-
sion culture where the FBS was reduced to 5% . Cells grown in monolayer
were routinely passaged with trypsin-EDTA (Gibco Laboratories) and cell
number wasdetermined with celloscope (Electro Zone, Particle Data, Inc.,
Elmhurst, IL). The CHO Fn"eficient variants used in this series of ex-
perimentswerepreviously selected from nonmutagenizedCHO populations
(Schreiner et al., 1989). Independent selections yielded two subsets ofFnR-
deficient variants expressing either 20% (clones 1-23, 14-16, and 21-4) or
2 % (clonesB2, Dl, 9, 23, and25) ofFnR whencomparedtowild-type (con-
trol) cells. For these studies we used clones 1-23 and 21-4 from the 20%
FnR subset, and clones B2 and 25 from the 2 % FnR subset.
Transfection ofPnR-deficient Variants
A 2% FnR-variant clone, B2, was chosen for reversion ofthe FnR-deficient
phenotype. Cells were revertedby transfectiog a plasmid (pECE-a5) which
is an expression vector for the human a5 subunit (Giancotti and Ruoslahti,
1990). Cells were cotransfected with a neomycin-resistantplasmid, pSVNeo,
for selection purposes. B2 cells were transfected by electroporation as de-
scribed in the Bio-Rad Methods in Electroporation manual (Bio-Rad Lab-
oratories, Richmond, CA). Briefly, cells were grown in monolayer, har-
vested with trypsin-EDTA, and washed twice in ice cold electroporation
media. The cells were then resuspended at a density of 1 x 101 cells/ml.
Cells werethen added to electroporation0.4-cm Gene Pulser cuvettes (Bio-
Rad Laboratories) and 20 leg ofpECE-a5 and 2 F+g of pSVNeo were added
to the curvettes and incubated with the cells on ice for 10 min. before elec-
troporation. Both plasmids had been linearized within a PVU-I restriction
site before addition to the cells to facilitate insertion of the plasmids into
hostchromosomal DNA. Cells werepulsed usingvoltages between200 and
800 V with a constant capacitance of25 p.F. Cells were selected with G418
(1,000 pg/ml) and isolated using cloning rings. After cloning, transfectants
were maintained in normally supplemented alpha-MEM containing 400
Wg/ml G418. Cells were screened for expression of the chimeric human
a5/hamster ßl FnR by ELISA and by flow cytometry using the BIE5 anti-
human 0 antibody (generous gift of C. Damsky, University of California
at SanFrancisco) (Werb et al., 1989). Five subsets ofclones were obtained
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from the transfection (B2ß1-B2B5). Based on ELISA data, clone 132134
showed the highest level of a5ß1 expression.
Integrin Analysis
The expression of the a5ß1 FnR, VnR, and the integrin ßl subunit was
evaluated by indirect immunofluorescence using flow cytometric tech-
niques. PBl (a mouse monoclonal anti-FnR antibody specific for the intact
CHO 001 complex), 7132 (a mouse monoclonal antibody specific for the
CHO ßl integrin subunit), BlE5 (a rat monoclonal anti-human a5 anti-
body), and rabbitpolyclonal antiVhR (avß3) antibody (Suzuki et al., 1986)
were used as primary antibodies, and FITC-conjugated IgG (anti-mouse or
anti-rabbit) was used as a secondary reagent. The PBl and 7132 mono-
clonals have been fully described elsewhere (Brown and Juliano, 1985,
1988) . Background staining was assessed by omitting theprimary antibody.
The FnR-deficientcells were screened by an ELISA technique as described
(Schreiner et al., 1989) to confirm the phenotype. The FnR-deficient vari-
ants were periodically screened thereafter by ELISA using PBl, to ensure
stability of the variant phenotype.
ExtracellularMatrix Proteins
Fn was prepared from human plasma as described (Schwartz and Juliano,
1984). Vn was also prepared fromhumanplasma ina modification (Danilov
and Juliano, 1989) of a previously published procedure (Ruoslahti et al.,
1987).
Adhesion Assay
Tissueculture plates (48-well, Costar Corp., Cambridge, MA) were coated
for 2 h with 250 lel of PBS containing Fn or Vn at varying concentrations.
The plates were then washed with PBS, blocked with 3% BSA in PBS, and
finally washed four times with alpha-MEM containing 1% BSA and20 mM
Hepes, pH 7.3 (adhesion buffer). Cells growing in suspension were meta-
bolically labeled overnight with 35STrans label (2-5 ACi/ml, 1,000
Ci/mM; ICN Biomedical, Inc., Costa Mesa, CA). Cells were washedthree
times and resuspended at 1-5 x 105 cells/ml in adhesion buffer. Cells were
added to the plates and allowed to attach to the substrata for 1 h at 37°C.
Atthe end ofthis time, unattached cellswere removed by washing the plates
with adhesionbuffer. Attachedcells werelysed with 2 % SDS and the lysates
were transferred to scintillation vials for counting. All assays were per-
formed in triplicate and adhesion was expressed as a percentage of positive
control.
Motility Assays
The haptotactic motility experiments were performed using Transwell
motility chambers (Costar Corp.) in a slight modification of a previously
described assay (Albini et al., 1987; Schreiner et al., 1989). The Transwell
motility chambers contain anupper and lower well separatedby a tissuecul-
ture-treated polycarbonate membrane (polyvinyl-pyrrolidone free) with
an 8-pm-diam pore size. Motility experiments were performed by first
precoating the undersurface of the polycarbonate membrane with various
concentrations of Fn or Vn in PBS. Cells growing in suspension were
washed three times and resuspended in alpha-MEM containing 1% BSA;
the same medium was also placed in the lower chamber. Cells (2 x 105)
were added to the upper chamber and incubated at 37°C forvarying times.
At the end of the incubation period, the cells on the upper surface of
the membrane were removed using a cotton-tipped applicator, and visually
inspected under a microscope to ensurecomplete removal. The membranes
were fixed with neutral buffered formalin (2%) and stained withhematoxy-
lin. The membraneswere mounted on glass slides andthecells from at least
10 random microscopic fields were counted. All experiments were run
in triplicate and motility was expressed in terms of cells per high powered
microscopic field (HPMF). This assay measures haptotaxis, i.e., direc-
tional motility in the presenceof a gradient ofbound protein. Extensivecell
movement through the membrane was observed only when the adhesive
protein was present exclusively on the side of the filter facing the lower
chamber; when the adhesive protein was present on both sides of the filter,
movement through the filter was sharply reduced (Bauer, J., unpublished
observations). Kinetic motility experiments were preformed as described
above except the Transwell motility inserts were coated with fixed concen-
trations ofFn (30 ug/ml) orVn (5 wg/ml). Motility experiments performed
in the presence ofPBl anti-FnR antibody were also carried out essentially
as described above except thewashedcells were incubated with excess PBl
478in alpha-MEM containing 1% BSA at 37°C for 30 min. The cells were then
added to the upper chamber of the motility inserts and incubated for 8 h
at 37°C.
In some cases, additional motility studies were done by observing the
ability of cells to move randomly on a uniform substratum of Fn orVn using
a modification of an assay which has been fully described elsewhere (Ak-
iyama et al., 1989). In this assay, cells are allowed to migrate from an
agarose plug onto a substratum initially uniformly coated with an ECM
protein. The size of the cell outgrowth is then measured as a function of
time; in our case this was done using a microscope eyepiece with a measur-
ing grid. With CHO cells this assay requires 3-7 d, and several cell dou-
blings occur. The medium used was alpha-MEM supplemented with insu-
lin, transferrin, and selenium, but without serum. The substrata were
coated with 10 pg/ml of Vn or Fn.
Results
Variant CellSelectionandIntegrin ReceptorAnalysis
The FnR-deficient variants were selected from a normally
growing population of CHO cells (Schreiner et al ., 1989).
Flow cytometric analysis of several independent clones is
shown in Fig. 1 . Variants 1-23 and 21-4 exhibit a significant
decrease in FnR expressionwhen compared to control (wild
type), while expression of the FnR in variants B2 and 25 is
nearly abolished. These results are more apparent when the
data from the flow cytometer are quantitated and compared;
i .e., 1-23 and 21-4 (termed 20% FnR variants) show -20%
ofcontrol FnR expression, whileB2 and 25 (termed 2% FnR
variants) show 1-2% (Table I, first column) . The 20% and
2 % phenotypes of the variants were also confirmed by
ELISA (data not shown). Earlier work with the FnR variants
indicates that the defect in FnR expression is at the level of
mRNA of the a5 subunit (Schreiner et al., 1989). The 01
subunit is also present on the cell surface in reduced amounts
(Table I, third column); the reduction in Ol expression is due
to the decrease in intact a5ß1 FnR expression in the variant
cells.
av03 was also examined in the wild-type and variant CHO
cells. Vn is another ECM component and is important in
promoting the attachmentand spreading of cells on the ECM
(Hayman et al., 1985b). Previous experiments in our labora-
Figure 1. FACS histograms of
FnR expression on FnR variants.
Equal numbers of wild-type and
FnR variants were washed with
cold PBS, then treated with
anti-FnR mAb (13131) followed
by staining with fluorescein-
conjugated sheep anti-mouse
IgG (stippled histograms). Cells
not treated with PBl and
stained with fluorescein-conju-
gated sheep anti-mouse IgG
were used as negative controls
(clear histograms). A leftward
shift of the stippled histogram
relative to wild-type cells indi-
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cates a decrease in receptor ex-
pression. Each peak represents
10^ cells. Histograms A, wild type; histograms B, 20% FnR vari-
ant (1-23); and histograms C 2% FnRvariant (132). The abscissa
represents the logarithm ofthe fluorescence intensity, while the or-
dinate represents the number ofcells at each level of fluorescence.
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Table I. Integrin Expression Compared to Wild Type'
' Results are expressed as a percentage of the level of CHO wild-type cells
calculated from the mean channel fluorescence values obtained by immu-
nofluorescent staining followed by flow cytometric analysis.
tory (Bauer, J. S., and R. L. Juliano, unpublished data) have
shown that CHO cells adhere to and migrate on Vn. Thus the
VnR was chosen to study the effects of decreased FnR ex-
pression on the functionality of other integrins. VnR was ex-
amined by flow cytometric analysis using an antiVnR poly-
clonal antibody (Fig. 2). Both the 20 % and 2% FnR variants
show levels of VnR expression similar to wild-type cells.
This again is clearly evident when the data from the flow
cytometer are quantitated and differentially compared. (Ta-
ble I, second column).
Adhesion to Substrata
Wild-type CHO cells adhered maximally to Fn substrata at
a coating concentration of 2.5 pglml or greater (Fig. 3 A) .
The 20 % FnR variants showed levels ofadhesion to Fn simi-
lar to wild-type cells suggesting that 100% ofthe FnR is not
necessary to promote maximal adhesion ofCHO cells to Fn.
Adhesion of the 2% FnR variants to Fn, even at coating con-
centrations of 10 lAglml, is nearly abolished. An apparent
"spare receptor" phenomenon (Brown and Juliano, 1987) ex-
ists for the adhesion of CHO cells to Fn measured under the
conditions described here; however, the amount of receptor
becomes limiting in the adhesion process as the expression
of FnR drops to very low levels. If the shear stress applied
in the adhesion assay were higher, a greater fraction of the
total FnR might be required to maintain adhesion. Similar
adhesion experiments were also performed with Vn as the
Figure 2. FACS histograms of
VnR expression on FnR vari-
ants. Equal numbers of wild-
type and FnR variants were
washed with cold PBS, then
treated with antiVnRpolyclonal
antibodies followed by staining
with fluorescein-conjugated goat
anti-rabbit IgG (stippled histo
grams). Cells not treated with
the antiVnR antibodies before
staining with the fluorescein-
conjugated goat anti-rabbit IgG
were used as negative controls
(clear histograms). Each peak
represents 10° cells. Histograms
A, wild-type; histograms B, 20%
FnR variant (1-23); and histograms C 2% FaR variant (132). The
abscissa representsthelogarithmofthe fluorescence intensity, while
the ordinate represents the number ofcells at each level of fluores-
cence.
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Clone PB1
Primary Antibody
anti-VnR 7E2
1-23 22.0 96.0 30.0
21-4 20.0 120.0 23.0
B2 1 .0 104.0 18.0
25 1 .0 138.0 35.0100
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PROTEIN CONCENTRATION, Ag/ml
Figure 3. Efficiency of adhesion of CHO FnR variants to Fn- and
Vn-coated substrata. Tissue culture plates were coated with various
concentrations of (A) Fn or (B) Vn for 2 h at 37°C in PBS, then
blocked with BSA as described in Materials and Methods. Cells that
were metabolically labeled overnight with "STrans label were
washed and resuspended at 5 x 105 cells/ml in adhesion buffer.
Cells were allowed to adhere for 60 min. The adherent cells were
recovered and analyzed for radioactivity as described in Materials
and Methods. (o---O) wild-type; (*---*) 1-23; (6--n) 21-4;
(") B2; (o-c) 25.
coating protein. Clones 1-23 and 25 showed control levels of
adhesion to Vn, while clones 21-4 and B2 exhibited slightly
greater adhesion to Vn than wild type (Fig. 3 B) . These data
indicate that the FnR defect does not affect the adhesion of
CHO cells to Vn.
It has been shown that the a5ß1 FnR is involved in the motil-
ity of cells on Fn substrata and the motility response is
proportional to the Fn concentration (Furcht et al., 1984;
Lacovara et al., 1984; McCarthy et al., 1985; Straus et al.,
1989). Several types of motility exist including haptotaxis
(directed migration on ligands fixed to a substratum), che-
motaxis (directed migration towards a soluble ligand), and
random, nondirectional movement. Attempts have been made
to study haptotaxis and chemotaxis independently, but an
uncertainty still exists as to whether there are any fundamen-
tal differences between the two processes (Straus et al.,
1989).
Here we have examined the role ofthe FnR in thehaptotac-
tic motility ofCHO cells on Fn and Vn. Wild-type CHO cells
migrated on Fn (Fig. 4 A) at coating concentrations >1.0
Fcg/ml and showed maximal motility (235 cells/HPMF) at
100 pg/ml or greater. Clone 1-23 showed a decreased maxi-
mal motility on Fn, exhibiting -75 % of wild-type level. The
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Figure 4. Motilities ofCHO FnR variants on Fn and Vn. Theunder-
sidesofTranswell motility chamberinserts were coatedwith various
concentrations of (A) Fn or (B) Vn in PBS. Cells were washed and
resuspended in alpha-MEM containing 1 % BSA. 2 x 105 cells
were added to the upper chamber and the motility chambers were
incubated at 37°C for 8 h. Motility was quantitated by counting the
number of cells that migrated to the undersides ofthe membranes.
The results are averages ofat least 10 random high powered micro-
scopic fields. ((o-o) wild-type; (~~) 1-23 ; (moo) 21-4;
(A-~) B2; (o-o) 25.
other 20% FnR variant, 21-4, showed -30% of maximal
wild-type motility. The motility of 2 % FnR variants on Fn
was even less ; clone B2 showed -20% of maximal wild-type
motility, while the motility response of clone 25 was nearly
abolished.
Wild-type CHO cells showed maximal haptotactic motil-
ity (125 cell/HPMF) on Vn at coating concentrations of 2.5
,ug/ml or greater (Fig. 4 B). Migration of wild-type cells on
Vn was evident at protein coating concentrations >0.5 Ag/ml .
Motility data from the FnR variants on Vn were discordant
with expected results. Both the 20 % and 2 % FnR variants
showed similar but markedly reduced motility on Vn when
compared to wild-type cells. Even at Vn coating concentra-
tions of 10 p.g/ml; the motility of the FnR variants never ex-
ceeded 30% of wild-type. Thus, although FnR deficient cells
adhered normally to Vn, their haptotactic motility on Vn was
significantly impaired.
The motility results presented thus far have been from ex-
periments which were allowed to continue for 8 h. To explore
the possibility that the FnR variants require additional time
to achieve maximal migration, experiments were extended200
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Figure S Kinetics of CHO FnR variant motility on Fn and Vn.
Transwell motility inserts were coated with either 30 Ag/ml Fn (top)
or 5 jug/ml Vn (bottom) . 1 x 105 cells were added to the upper
chamber and incubated for various times at 37°C. Motility was
quantitated as before. (o-ß) wild-type; (*--e) 1-23 ; (moo)
21-4; (") B2; (1}-fl) 25.
to 24 h. For these experiments 1.0 x 105 cells were added
per well instead of 2 .0 x 105 cells, and higher concentra-
tions of proteins (30 ug/ml and 5 ug/ml, for Fn and Vn,
respectively) were used to coat the polycarbonate mem-
branes. Wild-type CHO cells showed greater motility on Fn
than the FnR-deficient variants (Fig. 5 A) at all time points
tested, except for the initial 2-h period. This initial lag period
is probably due to the adherence and spreading of cells on
the polycarbonate membrane followed by recognition of the
protein gradient. Further, even at 24 h neither the 20 % FnR
variants nor the 2% FnR variants achieved wild-type levels
ofmotility (exhibiting 46 and 21% of wild-type cell motility,
respectively). When the kinetics of motility of the FnR vari-
ants on Vn were tested (Fig. 5 B), a pattern similar to the
results presented in Fig. 4 were obtained; i.e., neither the
20% nor the 2 % FnR variants were able to achieve control
levels of motility despite the fact that normal levels of VhR
are present on the surface of the variants. From these results,
we conclude that the decrease in haptotactic motility of the
FnR variants on Fn or Vn was not due to an increased initial
lag period.
Effects ofAntibodies on Motility
A concern in these studies was possible contamination ofour
Vn preparation by Fn, or cross-recognition of Vn by the FnR
(Basara et al., 1985) in the absence of Fn on the substratum.
To explore these possibilities, PBl, a monoclonal antibody
which bindsto and inhibits the intact FnR, was used in motil-
ity experiments to block the involvement of the FnR. Motil-
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Figure 6. The effect of anti-FnR antibody on CHO FnR variant mo-
tility on Fn. Transwell motility inserts were coated with various
concentrations ofFn. Cellswere washed and resuspended in alpha-
MEM containing 1% BSA. Excess PBl antibody was added to 2
x 105 cells and incubated for 30 min at 37°C. The cells were then
added to the upper chamber and incubated for 8 h at 37°C. Mo-
tility was quantitated as before. (A) (o- o), wild-type (-PBl) ;
(0- - -e), wild-type (+PBI). (B) (6-n), 1-23 (-PBI); (A- - -A),
1-23 (+PBI); (a--0), 21-4 (-PBI); (m- - -m), 21-4 (+PBl).
(C) (p--0), B2 (-PBl) ; ( " - - -"), B2 (+PBI); (v---v), 25
(-PBl); (v- - -v), 25 (+PBl).
ity of wild-type cells on Fn in the presence ofPB1 was nearly
abolished (Fig. 6 A). Motility of the 20% and 2% FnR vari-
ants was also markedly reduced in the presence of the PBl
antibody (Fig. 6 B and C). Thus, reduction in cell motility
on Fn appeared to be directly related to the reduction in the
amount of functional FnR present caused by the inhibitory
action ofthe PBl antibody. The basis of the small degree of
residual mobility in the presence of PBl is unknown; possi-
bly cell surface heparan sulfate proteoglycans, or alterna-
tively, expression ofthe 001 integrin may permit a low level
of interaction with Fn (Giancotti and Ruoslahti, 1990), espe-
cially when a5ß1 is not available (Elices et al., 1991) .
Data from motility experiments performed on Vn (Fig. 7)
in the presence ofPBl show that inhibition of the binding ca-125
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Figure 7 . The effect ofanti-FnR antibody on CHO FnR variantmo-
tility on Vn. Transwell motility inserts were coated with various
concentrations ofVn. Cellswere washed and resuspended in alpha-
MEM containing 1% BSA. Excess PBl antibody was added to 2 x
10° cells and incubated for 30 min at 37°C. The cells were then
added tothe upper chamber and incubated for 8 h at 37°C. Motility
was quantitated as before. (A) (o--O), wild-type (-PBl);
(9- - -e), wild-type (+PBI). (B) (o--d),
￿
1-23 (-PBI) ;
-A), 1-23 (+PBl);
￿
21-4 (-PBI); ("- - -E),
21-4 (+PBl). (C)
￿
B2 (-PBI); ("- _ -*), B2 (+PBl);
(v-v), 25 (-PBI); (v- - -v), 25 (+PBI) .
pacity of the FnR does not affect the motilitiesofeither wild-
type cellsor the FnR variants on this substratum. The motil-
ity of the wild-type cells remains aboutfivefold greater than
both the 20 % and 2% FnR variants. From these data it can
be concluded that blocking the binding ability of the FnR
does not affect the motility of cells on Vn.
Other experiments were performed to examine the possi-
bility ofcolocalization ofthe FnR with the VnR in CHO cells
during the formation of adhesion plaques on Vn. These ex-
periments were performed using indirect immunofluores-
cence using PB1 or the polyclonal antiVnR antibody. The
results from these experiments clearly demonstrate that the
FnR does not colocalize with the VhR in CHO cell focal con-
tacts (data not shown), in agreement with results in other cell
types (Fath et al ., 1989).
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Figure 8. (A) FACS histograms of a5 expression on the 2% FnR
variant, B2, and on the a5 transfectant (B2B4). Equal numbers of
each cell type were washed with cold PBS, then treated with anti-a5
mAb BIE5, followed by staining with fluorescein-conjugated goat
anti-rat IgG (stippled histograms) . Cells not treated with BlE5 and
stained with fluorescein-conjugated rabbit anti-mouse IgG were
used as negative controls (clear histograms) . (B) FACS histograms
of VnR expression on B2 and B2B4 cells. Equal numbers of each
cell type were washed with cold PBS, then treated with antiVnR
polyclonal antibodies followed by staining with fluorescein-conju-
gated goat anti-rabbit IgG (stippled histograms). Cells not treated
with the antiVnR antibodies before staining with the fluorescein-
conjugated rabbit anti-mouse IgG were used as negative controls
(clear histograms). (C) FACShistograms of 01 expression on B2,
and B2B4 cells. Equal numbers of each cell type were washed with
cold PBS, then treated withanti-ßl mAb, 7E2, followed by staining
with fluorescein-conjugated sheep anti-mouse IgG (stippled histo-
grams). Cells not treated with 7E2 and stained with fluorescein-
conjugated sheep anti-mouse IgG were used as negative controls
(clear histograms). Each peak represents 10° cells. Histograms I,
2% FnR variant, B2; histograms II, a5 transfectant, B2B4. The ab-
scissa represents the logarithm of the fluorescence intensity, while
the ordinate representsthe number of cells at each level of fluores-
cence.
Transfection ofFnR-deficient Variants with a5 cDNA
The data thus far suggest a cooperativity between the VnR
and FnR in the mobility of CHO cells on Vn. As stated
above, previous studies have shown the nature of the defect
in the FnRdeficient variants to be reduced expression of the
a5 subunit of FnR (Schreiner et al., 1989). To correct this
defect and to determine whether this was the only defect
causing the decrease in motility on Vn, a 2% FnR variant,
B2, was cotransfected with aplasmid containing a cDNA for
the human a5 subunit of the FnR, and a plasmid for neomy-
cin resistance. Five transfected clones were isolated and sub-
sequently screened by ELISA for a5 and ßl cell surface ex-
pression (data not shown). The clone showing the greatest
level of a5ß1 expression, B2B4, was chosen for further
study. Based on the ELISA data, 001 expression in the B2B4
clone was slightly greater than in wild-type levels. From
the flow cytometry results using the BlE5 anti-a5 antibody,
it is evident that the B2B4 clone expresses much more a5
than the original B2 clone (Fig. 8 A). Further, the levels of
ßl expression in the B2B4 clone were also increased (Fig.
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Figure 9. Efficiency of adhesion of a5 transfectants to Fn- and Vn-
coated substrata. Tissue culture plates were coated with various
concentrations of (A) Fn or (B) Vn for 2 h at 37°C in PBS, then
blocked with BSA as described in Materials and Methods. Cells
that were metabolically labeled overnight with 35STrans label
were washed and resuspended at 5 x 1(f cells/ml in adhesion
buffer. Cells were allowed to adhere for 60 min. The adherent cells
were recovered and analyzed for radioactivity as described in Ma-
terials and Methods. The upper graph shows adhesion of cells to
Fn-coated substrata. The lower graph shows adhesion of cells to
Vn. (o-o) wild-type; (o-a) B2; (*-A) B2B4.
8 B). Lastly, VnR levels in the B2B4 clonewere found to be
unchanged by the transfection procedure (Fig. 8 C).
Adhesion ofthe0Transfectants toFnand Vn
Although the transfected a5 subunit was recognized by the
BIE5 antibody, it remained to be seen whether the chimeric
a5ß1 (human a5/hamster ßl) could form a functional FnR
within CHO cells. Adhesion experiments were performed to
study the functionality of the hybrid 001. Results from
these experiments show that the B2B4 cells adhered to Fn
as well as wild-type (Fig. 9 A); as before, B2 cells failed
to adhere appreciably to Fn. Expression of the chimeric
a5ß1 had only minor effects on the adhesion of cells to Vn
(Fig. 9 B) .
Motility ofa5 TransfectantsonFn and Vn
Haptotactic motility ofthe B2B4 cellson Fn was nearly iden-
ticalto wild-type cells, whileB2 cells showed little motility
on Fn (Fig. 10 A). The results presented in Fig. 10 B show
that by bolstering a5ß1 expression in a5ß1 FnRdeficient
cells, haptotactic motility on Vn is restored. Motility of the
B2 clone on Vn, which had been attenuated presumably be-
cause of a lack of FnR expression, was restored after the a5
Bauer et al. Motility of Fibronectin Receptor-deficient Cells
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Figure 10. Motilities of a5 transfectants on Fn and Vn. The under-
sidesof Transwell motility chamber inserts were coated with vari-
ous concentrations of either (A) Fn or (B) Vn in PBS. Cells were
washed and resuspended in a-MEM containing 1% BSA. 2 x 105
cells were added to the upper chamber and the motility chambers
were incubated at 37°C for 8 h. Motility was quantitated by count-
ing the number of cells that have migrated to the underside of the
membrane. The results are expressed as averages of at least 10 ran-
dom high powered microscopic fields. (o-o) Wild-type; (e---*)
B2; (a--o) B2B4.
transfection. This clearly suggests an involvement of the
a5ß1 FnR in haptotactic cell motility on Vn. To ensure that
the decrease in motility on Vn was not due to an inability of
the B2 to spread after attachment, observations were made
of cellular spreading on 10 /ug/ml Fn and Vn . The photo-
graphs show that both wild-type and B2B4 cells spread well
on Fn whileB2 cells remain rounded (Fig. 11). All three cell
types, however, spread equally well on Vn.
A somewhat different picture emerged when we examined
nondirectional cell motility rather than haptotaxis. In these
studies we examined cell outgrowth from an agar plug onto
a uniformprotein-coated substratum. As seen in Table II, the
FnR-deficient clone B2 was very poorly motile on a Fn sub-
stratum, while in clone B2B4 (the a5 transfectant) motility
was restored to wild-type levels. On Vn substrata, all ofthe
clones were rather poorly motile, but the differences be-
tween wild-type cells and clones B2 or B2B4 were not
significant. This suggests that the presence or absence ofthe
a5ß1 FnR may affect directional motility more than random
motility.F
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.Table II. Random Motility ofFnR Variants and
Alpha 5 Transfectants
Discussion
Radius of Outgrowth on Fibronectin
Random motility wasevaluated by measuring cell outgrowth from an agar plug
attached to a protein-coated substratum, as described in Materials and Meth-
ods. The results represent the means and standard errors (in parenthesis) of
triplicate determinations . Results are expressed as the difference between the
radius of the outgrowth and the radius of the plug (in microns). The 3-d out-
growth on Vn was too small to measure accurately.
Cells have been shown to adhere to and migrate on a variety
of ECM proteins. These behaviors are mediated in part by
integrins which act as receptors for ECM proteins. The clas-
sic FnR, a501, is thought to exclusively bind Fn and to medi-
ate adhesion and motility of cells on substrata coated with
this protein (Akiyama et al ., 1990; Brown and Juliano, 1985;
Hemler, 1990; Pytela et al., 1985; Straus et al ., 1989) . This
manuscript confirms previous observations, i.e., that the
001 FnR is important in the adhesion and motility of cells
on Fn, but goes further to show that expression of FnR may
also be required for the directional motility of cellson other
substrata, particularly Vn. In CHO clones which express
normal levels of VhR, judged both by flow cytometry and by
adhesion to Vn, the lack of a5 expression leads to impaired
haptotactic motility on Vn. Transfecann of FnR-deficient
cells with a human 0 subunit leads to a restoration of hap-
totactic motility on Vn. Thus, expression of the 0 subunit
at normal levels seems to be required for normal motility on
Vn, even though the 001 integrin does not bind Vn .
An earlier study found that the expression of the 001
integrin in CHO cells reduced motility (Giancotti and Ruos-
lahti, 1990). However, only cells which expressed very high
levels of the integrin were affected in this manner. In a simi-
lar vein, Akiyama et al. (1989) reported that an anti-a5
monoclonal enhanced motility in human fibroblasts. It may
be that while some level of expression of a5f31 is required
for motility, very high levels become inhibitory ; thus in
some cases partial blockade of a5a1 may lead to enhanced
motility. Further, results with motility assays are often very
dependent on the nature of the assay used (Varani et al.,
1978) . The assays used by Giancotti and Ruoslahti (1990)
and by Akiyama et al. (1989) were cell outgrowth assays
reflectingmigration on a uniform substratum; in our case we
have primarily investigated directional motility. Our results
suggest that directional motility may be more strongly
affected by the level of 001 expression than is random cell
movement.
At this time we are unable to offer a definitivebiochemical
explanation for the effects of FnR expression on directed mo-
tility on Vn, but several reasonable hypotheses can be
Bauer et al. Motility ofFibronectin Receptor-de ficient Cells
delineated. One possibility stemsfrom the factthat integrins,
whileresponsible for recognizing and binding ECM proteins
extracellularly, also are involved in the reorganization of
cytoskeletal elements. When cells adhere to a substratum
coated with ECM proteins, focal adhesion plaques as well
as more transient adhesive contacts are initiated by the
clustering ofintegrin receptors. Within the cell, cytoskeletal
proteins (e.g., actin, a-actinin, vinculin, and talin) associate
with the cytoplasmic region of these integrin clusters (Bur-
ridge et al., 1988; Nuckolls et al., 1990; Otey et al., 1990).
These cytoskeletal interactions play a role in cell adhesion
and may play an even more critical role in directional motil-
ity of cells. It seems possible that in the absence of the a5o1
FnR, the cytoskeleton may fail to organize in a manner suit-
able for haptotactic motility, even though initial recognition
of substratum proteins is adequatelyprovided by other inte-
grins such as the av03 VnR. Thus cell adhesion is main-
tained but directional cell motility is impaired.
Another possibility is that in the wild-type CHO cell, the
a and Q subunits are produced in balanced amounts, but that
in the absence of a5 production in the variants, excess ,131
subunit exists. This excess ,131 may then complex with other
a subunits, particularly the cav subunit ofthe VhR. The resul-
tant av,Ql complex apparently does not recognize Vn (Ded-
har and Gray, 1990; Vogel et al., 1990), and its formation,
instead of cavs3, might thus limit motility on Vn. Previous
results (Schreiner et al., 1989) suggest that cell motility is
more sensitive to decreased integrin expression than is cell
adhesion. Thus reduction in the amount of ava3 could
markedly reduce motility on Vn without affecting adhesion
on this substrate. However, it seems unlikely that the level
of Sl subunit in the variants would necessarily impair av03
formation, since wild-type CHO cells also seem to express
an excess of (31 (Giancotti and Ruoslahti, 1990). Further,
surface labeling and immunoprecipitation experiments with
anti-av03 antibody followed by SDS-PAGE under conditions
where ,Q3 and al are clearly resolved, did not show any
reduction in the ratioofR3 to av in the precipitates from B2
or B2B4 cells as compared to wild-type cells, nor any evi-
dence for the presence of avlo1 complex (Bauer, J., and J.
Varner, unpublished data). While we cannot rule out small
changes in the association of av with other beta subunits,
there do not seem to be dramatic differences.
Yet another possibility relates to the growing evidence that
the a5a1 FnR has the ability to transduce signals to the cell
interior which can regulate gene expression and tumorige-
nicity (Giancotti and Ruoslahti, 1990; Kornberg et al., 1991;
Schreiner et al., 1991; Werb et al., 1989) . While the nature
ofthese signals and their relation to cell adhesion and motil-
ity are as yet poorly defined, it seems conceivable that they
might also regulate the directed motility of cells on a sub-
stratum.
Possibilities that have been clearly eliminated include Fn
contamination of the Vn substratum or 001 FnR-mediated
recognition of Vn. As shown in Figs. 6 and 7, treatment of
wild-type CHO cells with the PBl monoclonal antibody,
which blocks the function of the a501 FNR, essentially
completely inhibits haptotactic motility on Fn substrata, but
has no effect on haptotactic motility on Vn substrata. Thus,
it is unlikely that part of the motility of wild-type cells on
Vn couldbe attributed to contamination by Fn. Further, the
fact that the PBl antibody blocks adhesion and motility on
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Cell type Day 0 Day 3 Day 7
CHO WT 0 6.5 (2.2) 15.5 (1 .3)
B2 0 0 0
B2B4 0 5.2 (1.1) 18.3 (1 .3)
Radius of Outgrowth on Vitronectin
Cell type Day 0 Day 7
CHO WT 0 5.3 (2.6)
B2 0 4.4 (2.0)
B2134 0 7.1 (1 .4)Fn but not Vn, militates against the possibility that a5ß1
recognizes Fn. The possibility ofdirect physical association
of the FnR and VnR also seems unlikely. Colocalization of
FnR and VnR was explored using indirect immunofluores-
cence with antibodies to each receptor. Results clearly
showed that focal contacts are formed independently by the
receptors recognizing each protein, in agreement with previ-
ous results (Fath et al ., 1989) .
In summary, our results indicate that the expression of the
a5ß1 FnR is required for directed cell motility on Vn. Cells
which are deficient in FnR expression adhere well to Vn sub-
strata but are markedly impaired in theirability to be motile
on Vn gradients. Expression of a functional human a5/ham-
ster 01 FnR on the surface of the FnR-deficient variants by
transfection reverts the defect in directional motility. Al-
though there is no evidence for close juxtaposition of FnR
and VhR in cells adherent on Vn, the presence of the FnR
may be necessary to organize the cytoskeleton for motile ac-
tivity, or to transmit critical signals for motility. This func-
tion does not seem to require that the FnR bind its ligand,
since blocking the binding function of FnR with a monoclo-
nal antibody did not impair motility on Vn.
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